Optimize Financial’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
DTC
BBA
Optimize Financial's DSGN Position: Q3 2026 in Review
Optimize Financial opened a new position in Design Therapeutics (DSGN) in Q3 2026: 31,814 shares worth $400K. The stake represents 0.08% of the portfolio and ranks #229 among its holdings.
142 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- Optimize Financial held 31,814 shares of Design Therapeutics worth $400K as of Q3 2026.
- Design Therapeutics was a new Optimize Financial position in Q3 2026.
- Design Therapeutics made up 0.08% of Optimize Financial's portfolio in Q3 2026, its #229 holding.
- 142 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on Optimize Financial's 13F filing for Q3 2026, filed 12 Nov 2026.